The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray
The Journal.
Spravato: A Breakthrough in Depression Treatment
This chapter explores the FDA approval of Spravato, the first antidepressant to receive breakthrough designation, and its implications for the future of psychiatric treatment. It includes a personal story of recovery through Spravato and highlights the ongoing exploration of psychedelics in mental health therapies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
